Stock ORX OREXO AB
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Orexo AB

Equities

ORX

SE0000736415

Delayed Nasdaq Stockholm
Other stock markets
 07:31:34 2024-04-24 am EDT 		5-day change 1st Jan Change
16.58 SEK 0.00% Intraday chart for Orexo AB -5.26% +7.24%
Apr. 17 Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment MT
Apr. 17 Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ORX Stock
  4. Revisions Orexo AB